EcoDrugPlus

Utrophin

Ensembl ID : ENSCHYG00000019717
Gene Symbol: UTRN
1 Cross references
268 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSCHYG00000002863
Gene Symbol: VEGFA
1 Cross references
254 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSCHYG00000008988
Gene Symbol: VDR
1 Cross references
466 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSCHYG00000002159
Gene Symbol: VKORC1
1 Cross references
190 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSCHYG00000017425
Gene Symbol: XDH
1 Cross references
210 Possible Orthologues:

Ensembl ID : ENSCHYG00000016710
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSCHYG00000016970
Gene Symbol: -
Cross references: -
274 Possible Orthologues:

Ensembl ID : ENSCHYG00000015086
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSCHYG00000015077
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSCHYG00000014367
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSCHYG00000014309
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSCHYG00000014297
Gene Symbol: -
Cross references: -
330 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).